Incidence and prevention of liver transplantation- related cardiovascular complications
-
摘要: 肝移植是治疗急性肝衰竭、失代偿期肝硬化及肝细胞癌等终末期肝病的有效方法。近年,随着患者对医疗技术水平的认识和对术后生活质量要求的提高,肝移植已逐渐成为临床常见手术。从肝移植术前、术中及术后3个方面,阐述肝移植相关心血管并发症发生的原因和防治方法,旨在更好的认识和指导肝移植临床工作。Abstract: Liver transplantation is an effective treatment for acute liver failure, decompensated cirrhosis, hepatocellular carcinoma, and other end- stage liver diseases. In recent years, with the improvements in patients' understanding of medical technology and their requirement for postoperative quality of life, liver transplantation has become a common surgery in clinical practice. The causes and preventive methods for liver transplantation- related cardiovascular complications are reviewed from the aspects before, during, and after liver transplantation, aiming at a better understanding and guidance for clinical liver transplantation.
-
[1]ALBELDAWI M, AGGARWAL A, MADHWAl S, et al.Cumulative risk of cardiovascular events after orthotopic liver transplantation[J].Liver Transpl, 2012, 18 (3) :370-375. [2]VALENTINE E, GREGORITS M, GUTSCHE JT.Clinical update in liver transplantation[J].J Cardiothorac Vasc Anesth, 2013, 27 (4) :809-815. [3]FOUAD TR, ABDEL-RAZEK WM, BURAK KW, et al.Prediction of cardiac complications after liver transplantation[J].Transplantation, 2009, 87 (5) :763-770. [4]PREZ MJ, GARCA DM, TAYBI BJ, et al.Cardiovascular risk factors after liver transplantation:analysis of related factors[J].Transplant Proc, 2011, 43 (3) :739-741. [5]PERNEY P, SEGALAS F, NALPAS B, et al.Impact of tobacco and alcohol consumption in patients registered on waiting list on early morbidity following liver transplantation[J].Clin Res Hepatol Gastroenterol, 2013.[Epub ahead of print] [6]SUN XD, YE JF, FU Y, et al.Long-term management of the successful adult liver transplant:2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J].J Clin Hepatol, 2013, 29 (6) :1-15. (in Chinese) 孙晓东, 叶军锋, 付裕, 等.美国肝病学会和美国移植学会2012年实践指南:成人肝移植成功后的长期管理[J].临床肝胆病杂志, 2013, 29 (6) :1-15. [7]MANSELL H, WOROBETZ LJ, SYLWESTROWICZ T, et al.A retrospective study of the framingham cardiovascular risk scores in a liver transplant population[J].Transplantation Proc, 2013, 45 (1) :308-314. [8]WANG X, LU SC, WANG ML, et al.Relationship between QT interval prolongation and recent incidence of arrhythmia after liver transplantation[J].China Med Herald, 2012, 9 (22) :10-12. (in Chinese) 王鑫, 卢实春, 王孟龙, 等.QT间期延长与肝移植术后近期心律失常的关系[J].中国医药导报, 2012, 9 (22) :10-12. [9]WAN J, FAN SD.Clinical and basic research on liver transplantation for hepatocellular carcinoma[J].J Clin Hepatol, 2012, 28 (4) :243-244. (in Chinese) 万钧, 范上达.肝癌肝移植的临床及基础研究[J].临床肝胆病杂志, 2012, 28 (4) :243-244. [10]CHEN K, YANG HJ.Current perspectives on preoperative diagnosis and surgical management of portal vein thrombosis in patients requiring liver transplantation[J].J Clin Hepatol, 2013, 29 (4) :314-318. (in Chinese) 陈凯, 杨洪吉.合并门静脉栓塞的肝移植受体术前诊断与术式研究[J].临床肝胆病杂志, 2013, 29 (4) :314-318. [11]LEMYZE M, DHARANCY S, WALLAERT B.Response to exercise in patients with liver cirrhosis:Implications for liver transplantation[J].Dig Liver Dis, 2013, 45 (5) :362-366. [12]MILAN Z, GORDON J.The latest developments in liver transplantation[J].Trends in Anaesthesia and Critical Care, 2012, 2 (4) :161-165. [13]BERNAL V, PASCUAL I, PIAZUELO E, et al.Cystatin C level as a predictor of death and cardiovascular events after liver transplantation[J].Transplantation Proc, 2011, 43 (3) :732-734. [14]ZHAO S, FOSTER E, JOHN P, et al.Pre-transplant serum ferritin is associated with heart failure after liver transplantation[J].JACC, 2011, 57 (17) :278. [15]XU ZD, XU HT, YUAN HB, et al.Postreperfusion syndrome during orthotopic liver transplantation:a single-center experience[J].Hepatobiliary Pancreat Dis Int, 2012, 11 (1) :34-39. [16]ROBERTSON A.Intraoperative management of liver transplantation in patients with hypertrophic cardiomyopathy:a review[J].Transplant Proc, 2010, 42 (5) :1721-1723. [17] FOUAD TR, Abdel-Razek WM, Burak KW, et al.Prediction of cardiac complications after liver transplantation[J].Transplantation, 2009, 87 (5) :763-770. [18]MADHWAL S, ATREIA A, ALBELDAWI M, et al.Is liver transplantation a risk factor for cardiovascular disease?A meta-analysis of observational studies[J].Liver Transpl, 2012, 18 (10) :1140-1146. [19]IADEVAIA M, GIUSTO M, GIANNELLI V, et al.Metabolic syndrome and cardiovascular risk after liver transplantation:a singlecenter experience[J].Transplant Proc, 2012, 44 (7) :2005-2006. [20]RABKIN JM, ROSEN HR, CORLESS CL, et al.Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients[J].Transplant Proc, 2002, 34 (5) :1557-1558. [21]KAZANCI D, TURAN S, BOSTANCI B, et al.Cardiac arrest that developed during liver transplantation and intervention with cardiopulmonary bypass:Case report[J].Transplant Proc, 2012, 44 (6) :1759-1760. [22]SAKAI T, MATSUSAKI T, DAI F, et al.Pulmonary thromboembolism during adult liver transplantation:Incidence, clinical presentation, outcome, risk factors, and diagnostic predictors[J].Br J Anaesth, 2012, 108 (3) :469-477. [23]AUFHAUSER DD, ROSE T, LEVINE M, et al.Cardiac arrest associated with reperfusion of the liver during transplantation:Incidence and proposal for a management algorithm[J].Clin Transplant, 2012, 27 (2) :185-192. [24]ALBELDAWI M, AGGARWAL A, SAID M.Prediction of cardiovascular events following orthotopic liver transplantation (OLT) [J].J Hepatol, 2010, 52 (Suppl 1) :184.
本文二维码
计量
- 文章访问数: 2753
- HTML全文浏览量: 20
- PDF下载量: 571
- 被引次数: 0